Soft Tissue Cancer: Clinical Trials

6 trials for Soft Tissue Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 enrolling by invitation, 2 not yet recruiting. 2 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Enrolling by invitation 1, Not yet recruiting 1
Phase 22Completed 1, Not yet recruiting 1
Not applicable1Completed 1

Follow Soft Tissue Cancer: new trials by email Literature Review of Soft Tissue Cancer trials Research Report on Soft Tissue Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies
Moonshot Antibodies - Soft Tissue Cancer
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)162026-12-012026-09-22
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
Carbon Nanoparticle Iron Suspension for Injection - HNSCC, Soft Tissue Cancer
Phase 2Not yet recruitingSichuan Enray Pharmaceutical Sciences Company522026-03-272026-03-24
Prospective Registry of Histotripsy for Soft Tissue Tumors
Medical Record Review - Soft Tissue Neoplasm, Soft Tissue Cancer
Enrolling by invitationUniversity of California, San Francisco2002026-01-292026-10-06
Clinical Trial to Treat Stage IV Cancer Patients
Moonshot antibodies - Soft Tissue Cancer
Phase 1Enrolling by invitationMoonshot Antibodies122024-12-302025-09-22
A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma
HITS, Naxitamab + GM-CSF cycles, NICE - Refractory Neuroblastoma, Soft Tissue Cancer
Phase 2CompletedFundació Sant Joan de Déu472020-08-202024-08-29
Project HERO: Health Empowerment & Recovery Outcomes
Body Mind Training (BMT), Body Training (BT):, Usual Care (UC) - Prostate Cancer, Bladder Cancer
Not applicableCompletedRutgers, The State University of New Jersey1132017-07-312026-07-07

Narrower conditions

Sarcoma (6)  ·  Colonic Neoplasms (1)  ·  Fatigue (1)  ·  Kidney Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neuroblastoma (1)  ·  Prostatic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Soft Tissue Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Thyroid Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Neoplasms by Histologic Type (6)  ·  Neoplasms, Connective and Soft Tissue (6)  ·  Neoplasms (5)  ·  Neoplasms by Site (3)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)

Interventions

Injections (1)  ·  naxitamab (1)

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Fundació Sant Joan de Déu (1)  ·  Moonshot Antibodies (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Sichuan Enray Pharmaceutical Sciences Company (1)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  China (1)  ·  Spain (1)

Top investigators

Anita Y Kinney, PhD, RN (1)  ·  David Krag, MD (1)  ·  Michael R. Irwin, MD (1)  ·  Ryan Lokken, MD (1)  ·  Yongsheng Wang (1)

Results publications

PMID 40616105, PMID 42469198